METTL22

RNA expression — cross-omics
Cross-omicsRNA → MUTATIONPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, METTL22 RNA expression is significantly associated with the mutation status of many other genes, with 10,946 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible METTL22-associated genes across cancer lineages are TP53, F13B, and XIRP2. Each is linked with METTL22 in more than 6 cancer types. Because this analysis shows association rather than direction, both METTL22-to-partner and partner-to-METTL22 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, TP53 grouped by METTL22-low versus METTL22-high in LIHC.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (METTL22→partner) and Y-score (partner→METTL22) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LIHCTP53 →+1.640+0.238<.001<.00137
UCECF13B →+2.403+0.268<.001<.00134
UCECXIRP2 →+1.525+0.149<.001.00334
UCECFLG →+1.296+0.155<.001.00125
UCECSLIT3 →+2.868+0.268<.001<.00134
COADBRAF →-3.497-0.259<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest of 10,946 associations by consensus.

TP53 by METTL22 expression — LIHC

Box plot of TP53 in METTL22-low vs METTL22-high samples in LIHC.

Explore this box plot interactively →

Exploration